healthcare
AZ’s ‘blockbuster’ lung cancer drug fails, Q2 revenue falls
July 27, 2017Research and Development, Sales and Marketing AstraZeneca, biotech, drugs, healthcare, pharma, pharmaceutical
The long-awaited results for AstraZeneca’s Mystic trial have been revealed and, in a shocking setback for the company, it was …
Janssen single tablet regimen shows Phase 3 success in HIV
July 26, 2017Research and Development HIV, Janssen, biotech, healthcare, pharma, pharmaceuticals
The latest Phase 3 data investigating Janssen’s darunivir in the treatment of human immunodeficiency virus (HIV-1) showed that the drug …
FDA Chief plans regulatory overhaul to tackle US opioid crisis
July 25, 2017Manufacturing and Production, Sales and Marketing FDA, Scott Gottlieb, biotech, drugs, healthcare, opioid, pharma, pharmaceutical
The US faces an ongoing crisis in opioid dependency, and FDA Commissioner Scott Gottlieb is prepared to employ unusual tactics …
Lilly snaps up autoimmune drug in $400m biotech partnership
July 25, 2017Manufacturing and Production, Research and Development, Sales and Marketing Eli Lilly, Nektar, aceutical, biotech, drugs, healthcare, phar, pharma
Eli Lilly is to enter a partnership with Nektar Therapeutics to tap into the biotech’s new autoimmune disease therapy as …
Wave expands editorial and programme delivery teams with two appointments
July 24, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, healthcare, pharma, pharmaceutical
Specialist medical education company, Wave, has boosted its editorial and programme delivery teams with two new appointments. Sadaf Kazi joins …
The British Pharmacopoeia 2018 now available
July 24, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing British Pharmacopoeia, biotech, drugs, healthcare, pharma, pharmaceutical
The British Pharmacopoeia (BP) 2018 is now published and available for purchase. An essential text for anyone working to develop …
Teva to cut over 300 production jobs in Israel
July 24, 2017Manufacturing and Production, Sales and Marketing Teva, biotech, drugs, generics, healthcare, pharma, pharmaceutical
Teva, one of the world’s biggest generics firms and the biggest company in Israel, has revealed it plans to slash …
Top Ten most popular articles on Pharmafile.com this week
July 21, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Teva, biotech, brexit, drugs, healthcare, pharma, pharmaceutical, psoriasis, top ten
The week was characterised by two big psoriasis approval stories, while Amgen’s osteoporosis treatment was knocked back. Novartis CEO Joe …
Teva asthma treatment scores NICE approval
July 20, 2017Sales and Marketing Teva, asthma, biotech, cinqaero, drugs, healthcare, pharma, pharmaceuticals
NICE has reached a decision in its final appraisal determination of Teva’s Cinqaero (reslizumab), recommending the drug’s use as an …
Novel assay detects Zika, differentiates from dengue and other flaviviruses
July 19, 2017Research and Development Zika, assay, biotech, dengue, drugs, healthcare, pharma, pharmaceutical
A collaboration between Swiss antibody therapeutics firm Humab BioMed and the University of California, Berkeley has given rise to an …
FDA gives approval for Gilead’s hepatitis C therapy
July 19, 2017Research and Development, Sales and Marketing FDA, Gilead, US, Vosevi, biotech, drugs, healthcare, pharma, pharmaceutical
The FDA has announced that it has chosen to approve Vosevi (sofosbuvir/velpatasvir/voxilaprevir), Gilead’s investigational drug for the treatment of chronic …
Drug combinations can boost weight loss, research finds
July 19, 2017Research and Development biotech, drugs, healthcare, obesity, pharma, pharmaceuticals, weight loss
Researchers at the Perelman School of Medicine at the University of Pennsylvania have found that by combining specific hormone-based drugs …
Novartis CEO reasserts 2018 growth expectations, discusses Alcon and Sandoz future
July 18, 2017Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, biosimilars, biotech, healthcare, joe jimenez, leukaemia, pharma, pharmaceuticals
Novartis has reiterated its expectation of sales growth beginning in 2018, as well as a positive outlook for its Alcon …
Merck to lay off 200 as part of 5-year reorganisation plan
July 18, 2017Manufacturing and Production Merck, biotech, drugs, healthcare, pharma, pharmaceutical
German drug manufacturer Merck has announced its intention to streamline its manufacturing processes across Europe as part of a five-year …
Pharmafocus wants to hear from you!
July 17, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, biotech, drugs, healthcare, pharma, pharmaceutical
We are always looking for new ways to improve the next issue of Pharmafocus, and now we’re planning a new …
Latest content
MHRA approves Romvimza for tenosynovial giant cell tumour
Panthera opens clinical trial site at Keele University
